Get started
Author

Luca Proto

Observed names: L Proto, Proto, Luca
OpenAlex ID: A5092825645
Microbial signature of plaque and gut in acute coronary syndrome
2023 · Eugenia Pisano, Francesca Bugli, et al. · Scientific Reports · 12
PDF
Targeting Collagen Pathways as an HFpEF Therapeutic Strategy
2023 · Alice Bonanni, Ramona Vinci, et al. · Journal of Clinical Medicine · 11
PDF
ForePass endoscopic bypass device for obesity and insulin resistance—metabolic treatment in a swine model
2023 · Giulia Angelini, Manoel Galvao Neto, et al. · Gut · 8
PDF
Polygenic Risk Scores disclosure for cardiovascular prevention: Protocol of the Personalized HeartCare (PHC) trial
2026 · Luigi Russo, Luca Proto, et al. · PLoS ONE · 1
PDF
ForePass outperforms Semaglutide in weight control, glucose metabolism, and gut microbiota in swine
2025 · Sara Russo, Luca Proto, et al. · Diabetes Obesity and Metabolism · 1
Perceived risk of cardiovascular diseases in the Italian population: a baseline cross-sectional analysis of participants enrolled in the INNOPREV trial
2026 · Chiara de Waure, Ilaria Valentini, et al. · BMC Public Health
Awareness and perceived educational needs regarding personalised medicine: Cross-country differences from a European survey
2026 · Flavia Beccia, Francesco Andrea Causio, et al. · Public Health
Clinical utility of polygenic risk scores in cancer screening: A systematic review and meta-analysis
2026 · Luigi Russo, Stefania Boccia, et al. · OSF Preprints (OSF Preprints)
Projected Clinical Utility of Polygenic Risk Score-Stratified Cancer Screening: A Systematic Review
2026 · Eleonora Pascucci, Nicolò Lentini, et al. · SSRN Electronic Journal
Gut microbiota signatures in subclinical atherosclerosis: links to lipid metabolism and cardiovascular risk modulation
2025 · A D'aiello, S Morini, et al. · European Heart Journal
Gut microbiota, lifestyle, and atherosclerosis: unravelling microbial contributions to cardiovascular risk
2025 · A D'aiello, S Morini, et al. · European Heart Journal
INNOPREV trial: Polygenic Risk Scores and digital tools in personalized cardiovascular prevention
2025 · L Proto, L Russo, et al. · European Journal of Public Health
PDF
Integrating Polygenic Risk and Digital Interventions for Cardiovascular Prevention: Design and Preliminary Results of the INNOPREV Randomized Clinical Trial
2025 · Roberta Pastorino, Luigi Russo, et al. · Epidemiology Biostatistics and Public Health
Author response for " ForePass outperforms Semaglutide in weight control, glucose metabolism, and gut microbiota in swine"
2025 · Sara Russo, Luca Proto, et al.
Unconventional risk factors in cardiovascular diseases: A population based Italian cohort study
2025 · D'Aiello Alessia, Sofia Morini, et al. · Atherosclerosis
PDF
Unconventional Risk Factors in Cardiovascular Diseases: a Population–based Italian Cohort Study
2025 · A D‘Aiello, L Proto, et al. · European Heart Journal Supplements
Gut Microbiota and Subclinical Atherosclerosis: a New Emerging Perspective
2025 · A D‘Aiello, A Ruggio, et al. · European Heart Journal Supplements
Unconventional risk factors in cardiovascular diseases: a population-based Italian cohort study
2025 · A D'aiello, S Morini, et al. · European Journal of Preventive Cardiology
PDF
Gut microbiota and subclinical atherosclerosis: a new emerging perspective
2025 · A D'aiello, S Morini, et al. · European Journal of Preventive Cardiology
PDF
Citizen needs towards personalised medicine and genetic testing: results from a European survey
2024 · M Porcelli, F Beccia, et al. · European Journal of Public Health
Innovative Approaches for Personalized Cardiovascular Prevention: the INNOPREV multicentric trial
2024 · L Proto, L Russo, et al. · European Journal of Public Health
PDF
Health literacy in the evolving era of personalised medicine and digital health
2024 · F Beccia, F A Causio, et al. · European Journal of Public Health
Works count: 25
Citation count: 33
H-index: 3
I10-index: 2
Year
Topic
Type